4D Molecular Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
AKRO
Akero Therapeutics, Inc. |
$53.56 | $4.26 B | -14.27 | 69 |
IPSC
Century Therapeutics, Inc. |
$0.60 | $51.65 M | -2.22 | 140 |
KRON
Kronos Bio, Inc. |
$0.88 | $53.65 M | -0.81 | 8 |
EWTX
Edgewise Therapeutics, Inc. |
$15.42 | $1.62 B | -9.96 | 117 |
CGEM
Cullinan Oncology, Inc. |
$8.95 | $528.77 M | -3.23 | 111 |
MLYS
Mineralys Therapeutics, Inc. |
$14.92 | $971.76 M | -3.98 | 51 |
CCCC
C4 Therapeutics, Inc. |
$1.62 | $113.97 M | -1.08 | 110 |
GOSS
Gossamer Bio, Inc. |
$1.27 | $286.40 M | -5.73 | 144 |
FIXX
Homology Medicines, Inc. |
$0.93 | $3.02 M | -0.03 | 7 |
BCEL
Atreca, Inc. |
$0.09 | $3.57 M | -0.04 | 90 |
BMEA
Biomea Fusion, Inc. |
$2.61 | $97.50 M | -0.73 | 79 |
PASG
Passage Bio, Inc. |
$0.43 | $26.41 M | -0.42 | 60 |
BDTX
Black Diamond Therapeutics, Inc. |
$2.43 | $137.32 M | 40.25 | 24 |
RVMD
Revolution Medicines, Inc. |
$41.11 | $7.66 B | -9.91 | 616 |
STOK
Stoke Therapeutics, Inc. |
$11.82 | $645.34 M | 14.41 | 128 |
NVCT
Nuvectis Pharma, Inc. |
$8.83 | $185.12 M | -7.84 | 13 |
REPL
Replimune Group, Inc. |
$9.89 | $762.39 M | -3.22 | 479 |
LYRA
Lyra Therapeutics, Inc. |
$11.85 | $15.53 M | -0.19 | 30 |
TCRR
TCR2 Therapeutics Inc. |
$1.48 | $58.11 M | -0.35 | 58 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
